facebook-page-view
Advertisement

Dilip Shanghvi

Tanti & Shanghvi family end with 34% stake in Suzlon as open offer fails

Engineering

21 January, 2016

Tanti & Shanghvi family end with 34% stake in Suzlon as open offer fails

The open offer launched by billionaire Dilip Shanghvi-controlled entities along with promoters of Suzlon Energy Ltd to acquire additional 26 ......

Dilip Shanghvi's son Aalok to head emerging mkts unit after Sun Pharma buys Ranbaxy

Healthcare

12 March, 2015

Dilip Shanghvi's son Aalok to head emerging mkts unit after Sun Pharma buys Ranbaxy

Taking forward its acquisition of Ranbaxy Laboratories, Sun Pharma has put in place a team of top executives, including Dilip ......

Dilip Shanghvi overtakes Mukesh Ambani as richest Indian

General

05 March, 2015

Dilip Shanghvi overtakes Mukesh Ambani as richest Indian

Pharma tycoon Dilip Shanghvi today surpassed Mukesh Ambani as the world's richest Indian with a net worth of USD 21.5 ......

Sun Pharma promoters to buy 23% stake in Suzlon for $290M

Manufacturing

17 February, 2015

Sun Pharma promoters to buy 23% stake in Suzlon for $290M

Billionaire Dilip Shanghvi and his associates, the promoters of India's top drugmaker by market value Sun Pharma, are investing Rs ......

India's billionaires list rises to all time high of 56: Forbes

General

04 March, 2014

India's billionaires list rises to all time high of 56: Forbes

The number of Indian billionaires inched up to 56 with a collective net worth of $191.5 billion compared with last ......

Sun Pharma plans to acquire oral and injectable business to grow capacity

Healthcare

10 October, 2013

Sun Pharma plans to acquire oral and injectable business to grow capacity

Sun Pharmaceuticals Industries Ltd, Asia’s largest generic drugmaker by market value, in its bid to grow business faster than its ......

Sun Pharma to acquire Nasdaq-listed DUSA Pharma for $230M

Healthcare

08 November, 2012

Sun Pharma to acquire Nasdaq-listed DUSA Pharma for $230M

Mumbai-based Sun Pharma Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has struck another large overseas acquisition to buy ......